DONATE

IBEC to Develop Organs-on-a-Chip in Three Pathfinder Projects

BuonMarrow, OMICSENS, and PHOENIX-OoC are the three projects in which IBEC’s Biosensors for Bioengineering Group will apply its extensive knowledge in the field of biosensors and organs-on-a-chip. The projects, which will be developed with funding from the European Innovation Council’s prestigious Pathfinder Open program, promise to enhance cancer treatments and foster innovation in diagnostics.

An artificial muscle to study Duchenne muscular dystrophy

Developed by the IBEC, this system is created using patient cells and represents the first 3D muscle model capable of replicating the damage caused by Duchenne muscular dystrophy. The next phase of this project involves the development of an organ-on-a-chip platform, enabling more efficient preclinical studies of potential drugs and enhanced monitoring of muscle damage. Funding for this research has been provided by Duchenne Parent Project Spain, a non-profit association led by families with children affected by this form of dystrophy.

European funding for the treatment of Type 1 diabetes using 3D bioprinting

IBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal potential of research projects conducted in European institutions. Ramón’s project, Uniink, is centered on the treatment of Type 1 diabetes using cell therapy and 3D bioprinting.

IBEC researcher James Eills to meet with Nobel laureates

Dr. James Eills, researcher at IBEC, has been selected to attend the prestigious Lindau Nobel Laureate Meeting that brings together outstanding young scientists from around the world with Nobel laureates. This year, the event will be dedicated to Physiology & Medicine and will be held from 25th-30th June in Lindau, Germany.

Innovative bioengineered spheres might help treating diabetes

Researchers from IBEC, in collaboration with IDIBAPS in Barcelona, have developed nontoxic small spheres able to respond to variations in glucose levels, and producing insulin in vitro. These biomimetic spheroids containing pancreatic β-cells were prepared based on 3D bioprinting. This approach might help in the future improving clinical outcomes of β-cell transplantation strategies for diabetes treatment, as well as for in vitro drug screening platforms.

14th IBEC Symposium brings international experts and 300 attendees together

International experts and three hundred registered attendees met in the 14th IBEC Symposium, dedicated to regenerative therapies. Organised by the Institute for Bioengineering of Catalonia (IBEC), speakers presented the latest advances in mini-organs, organs on a chip, 3D bioprinting and tissue engineering, among others.

New biosensor detects inflammatory marker in muscle with high sensitivity

In a recent publication in the journal Nanophotonics, IBEC researchers present a new biosensor for the direct and sensitive detection of the protein interleukin-6 in muscle, an indicator of inflammation and potential disease, proving the high performance of the device on bioengineered 3D skeletal muscles. This new approach may result in a promising tool for measuring the efficacy of drug candidates for diseases where inflammation is present such as muscular dystrophy.